AJP - Endo AJP: Renal Physiology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
 QUICK SEARCH:   [advanced]


     


Am J Physiol Endocrinol Metab 255: E894-E902, 1988;
0193-1849/88 $5.00
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Tollefson, J. H.
Right arrow Articles by Albers, J. J.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Tollefson, J. H.
Right arrow Articles by Albers, J. J.

AJP - Endocrinology and Metabolism, Vol 255, Issue 6 E894-E902, Copyright © 1988 by American Physiological Society


ARTICLES

Regulation of plasma lipid transfer by the high-density lipoproteins

J. H. Tollefson, A. Liu and J. J. Albers
Department of Medicine, University of Washington School of Medicine, Seattle.

Mechanisms that regulate the activity of the plasma cholesteryl ester transfer protein (lipid protein transfer-I) are poorly understood. We have examined the role of endogenous regulators of the lipid transfer process, in particular the plasma high-density lipoproteins (HDLs), in both humans and two species previously reported to be devoid of cholesteryl ester transfer activity, the rat and the pig. Chromatography of d greater than 1.21 g/ml plasma on phenyl-Sepharose either enhanced (human) lipid transfer activity or unmasked (rat and pig) a nearly completely suppressed lipid transfer activity. The HDLs (either native or delipidated) were shown to be a rich source of a plasma lipid transfer inhibitor protein. Partial purification of the HDL-derived lipid transfer inhibitor protein was achieved by sequential chromatography on phenyl- and DEAE-Sepharose. Additional analysis of plasma from patients with very low (Tangier disease), normal, or very high levels of HDL cholesterol (hyperalphalipoproteinemia) revealed a significant inverse correlation between plasma cholesteryl ester transfer activity and the subjects HDL cholesterol level. These results suggest that circulating levels of the plasma high density lipoproteins may be an important determinant of plasma cholesteryl ester transfer activity, through the function of the HDL-derived lipid transfer inhibitor protein.


This article has been cited by other articles:


Home page
J. Biol. Chem.Home page
T. Gautier, D. Masson, M. C. Jong, L. Duverneuil, N. Le Guern, V. Deckert, J.-P. P. de Barros, L. Dumont, A. Bataille, Z. Zak, et al.
Apolipoprotein CI Deficiency Markedly Augments Plasma Lipoprotein Changes Mediated by Human Cholesteryl Ester Transfer Protein (CETP) in CETP Transgenic/ApoCI-knocked Out Mice
J. Biol. Chem., August 23, 2002; 277(35): 31354 - 31363.
[Abstract] [Full Text] [PDF]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
A. P. Serdyuk and R. E. Morton
Lipid Transfer Inhibitor Protein Defines the Participation of Lipoproteins in Lipid Transfer Reactions : CETP Has No Preference for Cholesteryl Esters in HDL Versus LDL
Arterioscler Thromb Vasc Biol, March 1, 1999; 19(3): 718 - 726.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. J. Hime, P. J. Barter, and K.-A. Rye
The Influence of Apolipoproteins on the Hepatic Lipase-mediated Hydrolysis of High Density Lipoprotein Phospholipid and Triacylglycerol
J. Biol. Chem., October 16, 1998; 273(42): 27191 - 27198.
[Abstract] [Full Text] [PDF]


Home page
J. Lipid Res.Home page
K.-A. Rye, M. Jauhiainen, P. J. Barter, and C. Ehnholm
Triglyceride-enrichment of high density lipoproteins enhances their remodelling by phospholipid transfer protein
J. Lipid Res., March 1, 1998; 39(3): 613 - 622.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
M. J. Liinamaa, M. L. Hannuksela, Y. A. Kesaniemi, and M. J. Savolainen
Altered Transfer of Cholesteryl Esters and Phospholipids in Plasma From Alcohol Abusers
Arterioscler Thromb Vasc Biol, November 1, 1997; 17(11): 2940 - 2947.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
B. Foger, A. Ritsch, A. Doblinger, H. Wessels, and J. R. Patsch
Relationship of Plasma Cholesteryl Ester Transfer Protein to HDL Cholesterol: Studies in Normotriglyceridemia and Moderate Hypertriglyceridemia
Arterioscler Thromb Vasc Biol, December 1, 1996; 16(12): 1430 - 1436.
[Abstract] [Full Text]


Home page
Arterioscler. Thromb. Vasc. Bio.Home page
L. Lagrost, E. Florentin, V. Guyard-Dangremont, A. Athias, H. Gandjini, C. Lallemant, and P. Gambert
Evidence for Nonesterified Fatty Acids as Modulators of Neutral Lipid Transfers in Normolipidemic Human Plasma
Arterioscler Thromb Vasc Biol, September 1, 1995; 15(9): 1388 - 1396.
[Abstract] [Full Text]


Home page
J. Biol. Chem.Home page
T. Gautier, D. Masson, J.-P. P. de Barros, A. Athias, P. Gambert, D. Aunis, M.-H. Metz-Boutigue, and L. Lagrost
Human Apolipoprotein C-I Accounts for the Ability of Plasma High Density Lipoproteins to Inhibit the Cholesteryl Ester Transfer Protein Activity
J. Biol. Chem., November 22, 2000; 275(48): 37504 - 37509.
[Abstract] [Full Text] [PDF]


Home page
J. Biol. Chem.Home page
N. Settasatian, M. Duong, L. K. Curtiss, C. Ehnholm, M. Jauhiainen, J. Huuskonen, and K.-A. Rye
The Mechanism of the Remodeling of High Density Lipoproteins by Phospholipid Transfer Protein
J. Biol. Chem., July 13, 2001; 276(29): 26898 - 26905.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Visit Other APS Journals Online